Latest Articles

Microdosing psychedelics like LSD and psilocybin is gaining popularity, but science remains inconclusive. Small studies report modest benefits in mood, focus and sleep, though placebo effects loom large.

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.

This article explores some of the reasons animal models are used in neuroscience and how this could change in the future.

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto Watamura could be vital.

Scientists have developed SMART (silently mutate and repair template), a strategy that dramatically expands the editable range of CRISPR targets by redesigning the repair template without changing the enzyme.

Read how the North African Dementia Registry will use multiomics data to reveal new insights on Alzheimer’s genetic risk.

Discover how scientists imaged the Parkinson’s protein PINK1, unlocking insight into its role in mitochondrial quality control and brain cell survival.

In this interview, Dr. Elizabeth Neumann discusses her journey into science, her research utilizing single-cell analysis and her commitment to mentorship and advocacy.

In this interview, Technology Networks spoke with Dr. Joanna Bowtell, professor of physiology, nutrition and metabolism, to learn more about her decorated career, from pioneering research to leadership roles.

Around 50–90% of brain tumor patients that survive at least 6 months after radiotherapy experience some form of cognitive decline, such as memory loss. In a systematic review, we examined damage to the normal brain tissue after brain irradiation.